Evidence map›Paper›PMID 31639228›Full record

ArticleJournal of veterinary internal medicine2019

MicroRNA expression in the cerebrospinal fluid of dogs with and without cervical spondylomyelopathy.

Daniella P Vansteenkiste, Joelle M Fenger, Paolo Fadda, Paula Martin-Vaquero, Ronaldo C da Costa

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. MicroRNA Expression Variation in Female Dog (Animals : an open access journal from MDPI · 2022
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Daniella P VansteenkisteDepartment of Veterinary Clinical Sciences, The Ohio State University, College of Veterinary Medicine, Columbus, Ohio.ORCID https://orcid.org/0000-0001-6506-6455
Joelle M FengerDepartment of Veterinary Clinical Sciences, The Ohio State University, College of Veterinary Medicine, Columbus, Ohio.
Paolo FaddaComprehensive Cancer Center, Genomics Shared Resource, The Ohio State University, Columbus, Ohio.
Paula Martin-VaqueroFreelance Medical and Veterinary Writer, Madrid, Spain.
Ronaldo C da CostaDepartment of Veterinary Clinical Sciences, The Ohio State University, College of Veterinary Medicine, Columbus, Ohio.
The Ohio State University · USDepartment for Work and Pensions · GB

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Dissecting the role of miR-9 in normal and malignant mast cell biologyK01OD019923 · OD · OHIO STATE UNIVERSITY · PI FENGER, JOELLE M · 2015 to 2019
$654k
NCI NIH HHS P30 CA016058NIH HHS K01 OD019923
6 · The paper itself

Abstract

backgroundOsseous-associated cervical spondylomyelopathy (OA-CSM) is a common condition of the cervical vertebral column that affects giant dog breeds. MicroRNAs (miRNAs) are small RNAs that regulate gene expression, and recent data suggest that circulating miRNAs present in biological fluids may serve as potential biomarkers for disease. The miRNA profiles of cerebrospinal fluid (CSF) from healthy dogs and dogs clinically affected by OA-CSM have not been described.

objectiveTo characterize the expression levels of miRNAs present in the CSF of normal Great Danes and identify differentially expressed miRNAs in the CSF of Great Danes clinically affected with OA-CSM. ANIMALS: Client-owned dogs: 12 control, 12 OA-CSM affected.

methodsCerebrospinal fluid samples were collected prospectively. MicroRNA expression was evaluated using the NanoString nCounter platform and quantitative real-time PCR.

resultsWe identified 8 miRNAs with significant differential expression. MiR-299-5p and miR-765 had increased expression levels in the CSF of OA-CSM-affected dogs, whereas miR-494, miR-612, miR-302-d, miR-4531, miR-4455, and miR-6721-5p had decreased expression levels in OA-CSM affected dogs compared to clinically normal dogs. Quantitative real-time PCR was performed to validate the expression levels of 2 miRNAs (miR-494 and miR-612), and we found a 1.5-fold increase in miR-494 expression and a 1.2-fold decrease in miR-612 in the CSF of the OA-CSM affected group (P = .41 and .89, respectively). CONCLUSIONS AND CLINICAL IMPORTANCE: Data generated from our study represent an initial characterization of the miRNA profile of normal canine CSF and suggest that a distinct CSF miRNA expression profile is associated with OA-CSM.

Indexed as

Cervical VertebraeGene Expression RegulationAnimalsDog DiseasesDogsMicroRNAsSpinal Cord CompressionSpinal StenosisTranscriptomeMicroRNAscerebrospinal fluidcervical spondylomyelopathyGreat DanesmicroRNAmiR-494miR-612Wobbler syndrome

Identifiers

PMID31639228
PMCPMC6872614
OpenAlexW2982150246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.